The Diabetes Discovery on the Real FDA Road

This is NOT medical advice and NOT a cure claim. It maps the Diabetes Mechanism Analysis license onto the real FDA approval road, explains what happens if it is never accepted as a drug, and shows the one lawful way it can still reach people — as a dietary supplement (which by law cannot claim to treat or cure diabetes).

01   How to read this

Start with the master guide, then this page, then the giveaway itself:

• The True-to-Life Method of Filing an FDA-Approved Medicine — the full approval road, start to finish.
• This page — the Diabetes discovery placed on that road.
• Sister companions: The Alzheimer’s Discovery and The Parkinson’s Discovery on the Real FDA Road.
• The licensed package itself: Licensed Research: Diabetes Mechanism Analysis.

All are in the Licensed Research category: cri-one.com/store/licensed-research.html.

02   What the diabetes discovery actually is

A computational discovery (Alchemy Data V2) cross-checked against published science — a small family of evidence-graded elemental signatures:

Safety-informed 30-day formula: zinc capped at 30 mg/day (below the 40 mg UL), copper 2 mg to prevent zinc-induced copper depletion, zinc and magnesium dosed separately (AM/PM), iron excluded (pro-oxidant risk to beta cells).

Intellectual property: a full patent application is prepared and ready to file — “Novel Metal-Amino Acid Complexes and Methods for Treating Diabetes,” 20 claims.

03   Where it sits on the FDA road

Stage 0 — Discovery & Preclinical  ·  YOU ARE HERE (pre-IND)
Stage 1 — IND application (Form 1571) · not yet started
Stage 2 — Phase 1 / 2 / 3 trials · not yet started
Stage 3 — NDA filing (Form 356h) · not yet started
Stage 4 — FDA review + cGMP inspection · not yet started
Stage 5 — Approval decision · not yet reached
Stage 6 — Post-market · not yet reached

• Phase 2/3 endpoint: HbA1c reduction vs control, plus fasting plasma glucose — clinically meaningful and durable.
• Cardiovascular safety data is typically required (large, long, expensive).
• Honest catch: human evidence is for simple zinc salts and magnesium giving modest improvement — no trial has tested these specific complexes as a diabetes drug.

“Ready to file” is not “FDA-approved.” A patent (USPTO) protects the idea; FDA approval is the separate safety-and-efficacy road. Both can be true at once.

04   What if there is no acceptance?

• Clinical hold — the FDA stops the IND in the first 30 days; trials never begin.
• Trial failure — no HbA1c benefit or a safety signal. The most common outcome; only ~1 in 10 drugs entering trials is approved.
• Refuse-to-File / Complete Response Letter — approval withheld pending fixes, sometimes forever.
• No funding at all — the most likely case for an independent discovery; 10–15 years and hundreds of millions of dollars without a pharma partner.

If any happen, three honest options remain: license/sell the patent, keep it open as licensed research, or make it as a dietary supplement — the one route that needs no FDA approval.

05   The one lawful way to make it: a dietary supplement

A dietary supplement is the only ingestible health product an independent maker can lawfully sell without FDA pre-approval (DSHEA, 1994). The trade: a supplement may never claim to diagnose, treat, cure, or prevent a disease — saying “cures diabetes” or “lowers blood sugar” makes it an illegal unapproved drug.

1. Use only legal dietary ingredients — zinc, magnesium, copper are established (pre-Oct-15-1994).
2. File a New Dietary Ingredient (NDI) notification 75 days before sale for anything newer.
3. Manufacture under supplement cGMP (21 CFR Part 111).
4. Label per 21 CFR 101 (Supplement Facts panel, ingredients, directions, warnings).
5. Make only structure/function claims; include the FDA disclaimer; notify the FDA within 30 days; hold substantiation.
6. Stay responsible for safety; report serious adverse events.

Required on every structure/function claim: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Bottom line: reachable without FDA approval — but it means selling a support product, not a cure, and never promising to treat diabetes. That gap is the frustrating part.

Inquiries

Christopher Gabriel Brown — Inventor & Licensor

crioneaka@outlook.com  · 
1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA

Related work by the same author: Chemical Cooker Laboratory — cri-one.com/store/chemical-cooker-laboratory.html

Educational only. Not medical, legal, or regulatory advice; not a claim that any compound is a cure; not affiliated with or endorsed by the FDA or USPTO. The discovery is supplement-grade research, not an FDA-approved drug. Dietary-supplement rules (DSHEA, NDI, 21 CFR 101/111) change over time — confirm current requirements with the FDA and qualified counsel before manufacturing or labeling anything. Do not self-treat; consult a licensed physician. USA buyers only; sales subject to Georgia (Gwinnett County) law.

© 2026 Christopher Gabriel Brown. All rights reserved. “Cri-One” and “Licensed Research” are product designations of the licensor. Patents retained; not sold.